Home Cart Sign in  
Chemical Structure| 1208315-24-5 Chemical Structure| 1208315-24-5

Structure of N6022
CAS No.: 1208315-24-5

Chemical Structure| 1208315-24-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

N6022 reversibly inhibits s-nitrosoglutathione reductase (GSNOR) with IC50 and Ki of 8 nM, 2.5 nM, respectively.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of N6022

CAS No. :1208315-24-5
Formula : C24H22N4O3
M.W : 414.46
SMILES Code : OC(CCC1=CC=C(N1C2=CC=C(C(N)=O)C=C2C)C(C=C3)=CC=C3N4C=CN=C4)=O
MDL No. :MFCD22123247
InChI Key :YVPGZQLRPAGKLA-UHFFFAOYSA-N
Pubchem ID :44623946

Safety of N6022

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Beas2b cells 10 µM 12 hours GSNO or N6022 treatment significantly alleviated CSE-induced ROS activation. Antioxid Redox Signal. 2017 Sep 1;27(7):433-451
Beas2b cells 10 µM 12 hours GSNO or N6022 treatment significantly inhibited CSE-induced decrease in membrane CFTR expression by rescuing it from ubiquitin-positive aggresome bodies. Antioxid Redox Signal. 2017 Sep 1;27(7):433-451
tomato fruit cells 60 µM 12 days Delayed tomato fruit ripening, increased total chlorophyll content by 88.57%, and reduced total carotenoid and lycopene contents Int J Mol Sci. 2024 Feb 27;25(5):2729

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Myocardial ischemia-reperfusion injury model Perfusion 100 nmol/L or 10 μmol/L 15 minutes prior to ischemia and 5 minutes at the start of reperfusion To evaluate the effect of GSNO-R inhibition on myocardial ischemia-reperfusion injury. Results showed that GSNO-R inhibition reduced injury in male hearts but exacerbated injury in female hearts. Circ Res. 2018 Nov 9;123(11):1232-1243
C57BL/6 J mice Experimental autoimmune encephalomyelitis (EAE) model Intraperitoneal injection 1 mg/kg body weight Daily starting from day 9 post-immunization N6022 treatment ameliorated EAE clinical disease, reduced B cell infiltration into the CNS, and modulated IL-10 and IL-6 expression Redox Biol. 2021 Sep;45:102053
Mice Myocardial ischemia-reperfusion injury model Perfusion 100 nmol/L or 10 μmol/L 15 minutes before ischemia and 5 minutes at the start of reperfusion To evaluate the effect of GSNO-R inhibition on myocardial ischemia-reperfusion injury. Results showed that N6022 treatment significantly reduced injury in male hearts but exacerbated injury in female hearts. Circ Res. 2018 Nov 9;123(11):1232-1243
Mice Murine sickle cell disease (SCD) model Subcutaneous injection 1 mg/kg/d Once daily for 3 weeks To investigate the effects of inhibiting GSNOR on vasodilation in SCD mice. Results showed that treatment with N6022 significantly improved endothelial-dependent and eNOS-dependent vasodilation in SCD mice. Free Radic Biol Med. 2024 Mar;215:112-126
C57BL/6 mice Chronic cigarette smoke-induced COPD-emphysema model Intratracheal administration 4 mg/kg body weight Three doses with a 3-day interval, for 18 weeks GSNO or N6022 treatment significantly alleviated chronic CS-induced inflammation, aggresome formation, oxidative/nitrosative stress, apoptosis, and alveolar airspace enlargement. Antioxid Redox Signal. 2017 Sep 1;27(7):433-451
C57BL/6J mice Acetaminophen-induced liver injury model Intraperitoneal injection 5 mg/kg Single injection, duration of 10 hours To evaluate the hepatoprotective effect of GSNOR inhibitor N6022, results showed that N6022 increased SNO-PXR levels, reduced liver necrosis and inflammatory responses. JCI Insight. 2024 Jan 23;9(2):e172632
Mice Gsnor−/− mice and wild-type mice Intraperitoneal injection 5 mg/kg To evaluate the effect of GSNOR inhibition on HSV-1 infection, results showed that N6022-treated mice were more susceptible to HSV-1 infection with higher mortality and severe immune cell infiltration in the lungs. Redox Biol. 2021 Nov;47:102172
Female C57BL/6 mice Experimental autoimmune encephalomyelitis (EAE) Intraperitoneal or oral 1 mg/kg body weight (i.p.) or 2.5 mg/kg body weight (oral) Daily treatment until the end of the study (day 41 post immunization) To evaluate the efficacy of N6022 on EAE disease. Results showed that N6022 treatment significantly attenuated the clinical disease of EAE, inhibited the polarization and CNS effector function of proinflammatory T cells (TH1 and TH17), while inducing the polarization and function of anti-inflammatory T cells (TH2 and Treg). Additionally, N6022 treatment protected against EAE-induced demyelination. Free Radic Biol Med. 2018 Jun;121:57-68
Tomato Tomato fruit Injection 60 µM Single treatment, lasted for 12 days Delayed tomato fruit ripening, increased endogenous NO content by 197.55% and SNOs content by 74.65% Int J Mol Sci. 2024 Feb 27;25(5):2729
C57BL/6 mice SARS-CoV-2 spike protein S1 domain-induced acute lung disease model Intraperitoneal injection 1 mg/kg/day Once daily for 5 days To evaluate the therapeutic effects of N6022 on SARS-CoV-2 spike protein S1 domain-induced acute lung disease. Results showed that N6022 treatment significantly reduced fever and body weight loss, decreased blood levels of pro-inflammatory cytokines and coagulation factors, and reduced lung inflammatory cell infiltration and fibrin deposition. Front Pharmacol. 2023 Dec 8;14:1304697

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.41mL

0.48mL

0.24mL

12.06mL

2.41mL

1.21mL

24.13mL

4.83mL

2.41mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories